QDEL Share Price

Open 19.83 Change Price %
High 19.91 1 Day -0.02 -0.10
Low 19.66 1 Week -0.27 -1.35
Close 19.74 1 Month -0.91 -4.41
Volume 82672 1 Year 2.40 13.84
52 Week High 23.94
52 Week Low 13.21
QDEL Important Levels
Resistance 2 19.97
Resistance 1 19.88
Pivot 19.77
Support 1 19.60
Support 2 19.51
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
APRI 2.86 89.40%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
APRI 2.86 89.40%
AMCF 0.06 50.00%
LOCM 0.09 50.00%
SKBI 0.12 50.00%
UNXL 1.69 34.13%
LIFE 3.25 32.65%
CHCI 2.42 29.41%
GLBS 6.17 27.22%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
THTI 0.15 -40.00%
More..

Quidel Corporation (NASDAQ: QDEL)

QDEL Technical Analysis 1.5
As on 18th Jan 2017 QDEL Share Price closed @ 19.74 and we RECOMMEND Buy for LONG-TERM with Stoploss of 19.53 & Sell for SHORT-TERM with Stoploss of 21.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
QDEL Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
QDEL Other Details
Segment EQ
Market Capital 592634944.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.quidel.com
QDEL Address
QDEL
10165 McKellar Court
San Diego, CA 92121
United States
Phone: 858-552-1100
Fax: 858-453-4338
Interactive Technical Analysis Chart Quidel Corporation ( QDEL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Quidel Corporation
QDEL Business Profile
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, women�s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors, and a direct sales force. Internationally, it sells and markets primarily in Japan and Europe through distributor arrangements. It provides diagnostic testing solutions under various brand names, including QuickVue, QuickVue+, Quidel, MicroVueTM, FreshCells , D3 FastPoint, Super E-Mix, ELVIS, Sofia , Quidel Molecular, and Thyretain. In May 2013, the Company completed the acquisition of BioHelix Corporation.